Priyanka Grover

Stock Analyst at J.P. Morgan

(0.15)

# 4,269

Out of 4,377 analysts

Total ratings

14.3%

Success rate

-50.5%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Priyanka Grover

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	RXRX Recursion Pharmaceuticals	Maintained: Buy	$11 → $10	$3.32	+201.66%	2	Apr 30, 2026
	MREO Mereo BioPharma Group	Maintained: Hold	n/a	$0.3132	-	7	Mar 25, 2026

Recursion Pharmaceuticals

Apr 30, 2026

Maintained: Buy

Price Target: $11 → $10

Current: $3.32

Upside: +201.66%

Mereo BioPharma Group

Mar 25, 2026

Maintained: Hold

Price Target: n/a

Current: $0.3132

Upside: -